Gastroenterology
The findings of a recent study suggest that the crosstalk between gut microbes and the host’s immune system can influence the body’s defenses during cancer therapy.
Johan van Hylckama Vlieg, CSO and Co-founder of Freya Biosciences, discusses the latest advancements in microbial immunotherapies for women's health.
The findings of a recent study suggest that different factors, including maternal seeding and phage persistence in the gut, contribute to the colonization of the gut by phages.
Shahram Lavasani, Founder & CEO at ImmuneBiotech AB, discusses the recent data about gut microbiota and Pre-eclampsia.
Although a causative relationship between obesity and gut microbes remains unclear, microbiota-based treatments may help to combat obesity.
The findings of a recent study shed light on the microbiota of the main nutrition types that preterm infants receive and may inform future studies on the influence of different…
Giovanni Barbara, congress chair, explain why it is important to be part of IBS Days 2024.
A recent study indicates that the abfA cluster might be used as therapeutic target for constipation in humans.
The findings of a recent study may inform new approaches to treat Crohn’s disease by targeting disease-causing microbes in the gut.
The findings of a recent study suggest that mycobiota changes during a SARS-CoV-2 infection could contribute to inflammation associated with severe COVID.
